Shearman & Sterling advised Caris Life Sciences in the equity portion of its $310 million growth capital financing. The financing includes a $235 million equity investment co-led by Highland Capital Management and Coatue, with participation from funds and accounts advised by T. Rowe Price Associates, Inc., OrbiMed, Millennium Management, Neuberger Berman, ClearBridge Investments, First Light Asset Management and other undisclosed investors. Sixth Street provided $75 million in debt and also participated in the equity round.

Headquartered in Irving, Texas, Caris Life Sciences is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation. 

The Team